Drug Type Small molecule drug |
Synonyms Unboosted protease inhibitor - Gilead Sciences, GS 1156, GS-1156 |
Target |
Action inhibitors |
Mechanism HIV-1 protease inhibitors(Human immunodeficiency virus type 1 protease inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC52H59F10N11O8 |
InChIKeyZTSLYWLHCOINNI-FTEFBJIISA-N |
CAS Registry2242428-57-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 1 | United States | 17 Jun 2020 |